Dimitrios Kordias (Dimitris Kordias)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

High Resolution Mass Spectrometry

Breast Cancer Cells

Top Venues

Molecules (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Konstantinos Ypsilantis, Evangelia Sifnaiou, Antonia Garypidou, Dimitrios Kordias, Angeliki Magklara, Achilleas Garoufis
Ruthenium-Cyclopentadienyl-Cycloparaphenylene Complexes: Sizable Multicharged Cations Exhibiting High DNA-Binding Affinity and Remarkable Cytotoxicity. Molecules (Basel, Switzerland) 29 (2) (2024)
Konstantinos Ypsilantis, Evangelia Sifnaiou, Antonia Garypidou, Dimitrios Kordias, Angeliki Magklara, Achilleas Garoufis
Ruthenium-Cyclopentadienyl-Cycloparaphenylene Complexes: Sizable Multicharged Cations Exhibiting High DNA-Binding Affinity and Remarkable Cytotoxicity. Molecules (Basel, Switzerland) 29 (2) (2024)
Spyros Foutadakis, Dimitrios Kordias, Giannis Vatsellas, Angeliki Magklara
Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis. International journal of molecular sciences 25 (13) (2024)
Spyros Foutadakis, Dimitrios Kordias, Giannis Vatsellas, Angeliki Magklara
Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis. International journal of molecular sciences 25 (13) (2024)
Konstantinos Ypsilantis, Evangelia Sifnaiou, Antonia Garypidou, Dimitrios Kordias, Angeliki Magklara, Achilleas Garoufis
Ruthenium-Cyclopentadienyl-Cycloparaphenylene Complexes: Sizable Multicharged Cations Exhibiting High DNA-Binding Affinity and Remarkable Cytotoxicity. Molecules (Basel, Switzerland) 29 (2) (2024)
Dimitrios Kordias, Christina E Kostara, Styliani Papadaki, John Verigos, Eleni Bairaktari, Angeliki Magklara
Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities. Cells 11 (17) (2022)